학술논문
Bortezomib-Dexamethasone, Rituximab, and Cyclophosphamide as First-Line Treatment for Waldenström's Macroglobulinemia: A Prospectively Randomized Trial of the European Consortium for Waldenström's Macroglobulinemia
Document Type
Article
Author
Buske, C.; Schmelzle, B.; Kaszynski, D.; Dimopoulos, M.A.; Kastritis, E.; Grunenberg, A.; Viardot, A.; Tomowiak, C.; Mahé, B.; Troussard, X.; Hajek, R.; Tournilhac, O.; Aurran, T.; Lepretre, S.; Zerazhi, H.; Hivert, B.; Leblond, V.; De Guibert, S.; Brandefors, L.; Garcia-Sanz, R.; Gomes Da Silva, M.; Kimby, E.; Dreyhaupt, J.; Muche, R.; Morel, P.
Source
In: Journal of Clinical Oncology . (Journal of Clinical Oncology, 10 May 2023, 41(14):2607-2616)
Subject
Language
English
ISSN
15277755
0732183X
0732183X